A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide) Sponsor:   Novo Nordisk A/S Not yet recruiting

Source: ClinicalTrials.gov - June 18, 2019 Category: Research Source Type: clinical trials